Upregulation of GSTO1 expression is reported for diverse cancers, including esophageal squamous cell carcinoma [11], colorectal cancer [12], non‐small‐cell lung cancer [13], and bladder cancer [14], and is associated with metastatic features and advanced cancer stages. The gene discussed is GSTO1; the disease is urinary bladder cancer.